208 related articles for article (PubMed ID: 37175905)
1. Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma-An Unexpected Correlation to Guide Future Treatment?
Lobbes LA; Schütze MA; Droeser R; Arndt M; Pozios I; Lauscher JC; Hering NA; Weixler B
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175905
[TBL] [Abstract][Full Text] [Related]
2. Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma.
Hering NA; Liu V; Kim R; Weixler B; Droeser RA; Arndt M; Pozios I; Beyer K; Kreis ME; Seeliger H
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203220
[TBL] [Abstract][Full Text] [Related]
3. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway.
Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
Tumour Biol; 2015 Jun; 36(6):4091-100. PubMed ID: 25964092
[TBL] [Abstract][Full Text] [Related]
4. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
[TBL] [Abstract][Full Text] [Related]
5. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
6. Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer.
Kuol N; Davidson M; Karakkat J; Filippone RT; Veale M; Luwor R; Fraser S; Apostolopoulos V; Nurgali K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614038
[TBL] [Abstract][Full Text] [Related]
7. Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjögren's syndrome.
Kudo H; Tsuboi H; Asashima H; Takahashi H; Ono Y; Abe S; Honda F; Kondo Y; Wakasa Y; Takaiwa F; Takano M; Matsui M; Matsumoto I; Sumida T
Mod Rheumatol; 2020 Sep; 30(5):884-893. PubMed ID: 31490711
[No Abstract] [Full Text] [Related]
8. Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer.
Ali O; Tolaymat M; Hu S; Xie G; Raufman JP
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450835
[TBL] [Abstract][Full Text] [Related]
9. R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR.
Lan L; Wang H; Yang R; Liu F; Bi Q; Wang S; Wei X; Yan H; Su R
Life Sci; 2019 Oct; 234():116742. PubMed ID: 31401315
[TBL] [Abstract][Full Text] [Related]
10. Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor.
Pronin AN; Wang Q; Slepak VZ
Mol Pharmacol; 2017 Nov; 92(5):601-612. PubMed ID: 28893976
[TBL] [Abstract][Full Text] [Related]
11. [M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis
and Adhesion in Small Cell Lung Cancer].
Wu W; Zhang S; Hu C
Zhongguo Fei Ai Za Zhi; 2016 Mar; 19(3):113-21. PubMed ID: 27009814
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.
Lin G; Sun L; Wang R; Guo Y; Xie C
J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413
[TBL] [Abstract][Full Text] [Related]
13. Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.
Felton J; Hu S; Raufman JP
Curr Mol Pharmacol; 2018; 11(3):184-190. PubMed ID: 29357811
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic Receptor M
Welliver RR; Polanco JJ; Seidman RA; Sinha AK; O'Bara MA; Khaku ZM; Santiago González DA; Nishiyama A; Wess J; Feltri ML; Paez PM; Sim FJ
J Neurosci; 2018 Aug; 38(31):6921-6932. PubMed ID: 29959237
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic M₃ receptors contribute to allergen-induced airway remodeling in mice.
Kistemaker LE; Bos ST; Mudde WM; Hylkema MN; Hiemstra PS; Wess J; Meurs H; Kerstjens HA; Gosens R
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):690-8. PubMed ID: 24156289
[TBL] [Abstract][Full Text] [Related]
16. No evidence of increased anti-M3 muscarinic acetylcholine receptor autoantibodies in SSA-positive connective tissue disease patients.
Hatipoğlu E; Mikkelsen JH; Korsholm TL; Hvid M; Deleuran B; Dahl MLN
APMIS; 2023 Oct; 131(10):552-555. PubMed ID: 37620885
[TBL] [Abstract][Full Text] [Related]
17. Role of the M3 muscarinic acetylcholine receptor subtype in murine ophthalmic arteries after endothelial removal.
Gericke A; Steege A; Manicam C; Böhmer T; Wess J; Pfeiffer N
Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):625-31. PubMed ID: 24408978
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
Iizuka M; Wakamatsu E; Tsuboi H; Nakamura Y; Hayashi T; Matsui M; Goto D; Ito S; Matsumoto I; Sumida T
J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
[TBL] [Abstract][Full Text] [Related]
19. Regulation of M₃ muscarinic receptor expression and function by transmembrane protein 147.
Rosemond E; Rossi M; McMillin SM; Scarselli M; Donaldson JG; Wess J
Mol Pharmacol; 2011 Feb; 79(2):251-61. PubMed ID: 21056967
[TBL] [Abstract][Full Text] [Related]
20. Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice.
Khurana S; Chacon I; Xie G; Yamada M; Wess J; Raufman JP; Kennedy RH
Eur J Pharmacol; 2004 Jun; 493(1-3):127-32. PubMed ID: 15189773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
